
Astiride MP 2mg/500mg/15mg Tablet SR
Marketer
Astakind Biotech Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Astiride MP 2mg/500mg/15mg Tablet SR
Metformin/pioglitazone/glimepiride extended-release tablets (2mg/500mg/15mg) are a combined medication to manage blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood sugar. Dosage and frequency should strictly follow your physician's instructions. Take it with food to minimize digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, omit the missed dose and resume the regular schedule. Never double a dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood sugar monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your doctor of any kidney, liver, or heart conditions before starting this medication. Pregnant or breastfeeding individuals require medical consultation prior to use. Kidney function tests are typically conducted before treatment begins. Limit alcohol consumption as it may heighten the risk of adverse effects.
Primary Ingredients of Astiride MP 2mg/500mg/15mg Tablet SR
The provided text is "undefined," therefore no rewriting is possible.
Uses of Astiride MP 2mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Astiride MP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Astiride MP 2mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Astiride MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Astiride MP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Astiride MP 2mg/500mg/15mg Extended-Release tablet should be administered with a meal.
How Astiride MP 2mg/500mg/15mg Tablet SR works:
Astiride MP 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Astiride MP 2mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Astiride MP 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice from your doctor.
Breast feedingCONSULT YOUR DOCTOR
Use of Astiride MP 2mg/500mg/15mg SR tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Astiride MP 2mg/500mg/15mg SR tablets, potentially requiring dosage modification. Consult a physician for guidance. Astiride MP 2mg/500mg/15mg SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Astiride MP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Astiride MP 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Astiride MP 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Astiride MP 2mg/500mg/15mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Astiride MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
